No Data
No Data
GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged
Businessolver Improves Access to Care Through Enhanced Provider Guidance
Is GoodRx Holdings (NASDAQ:GDRX) A Risky Investment?
Mizuho Initiates GoodRx Holdings at Neutral With $5 Price Target
Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS) and GoodRx Holdings (GDRX)
Express News | GoodRx Holdings Inc : JP Morgan Cuts Target Price to $7 From $10